Journal of Lipid Research
Volume 61, Issue 12, December 2020, Pages 1733-1746
Journal home page for Journal of Lipid Research

Research Articles
Bioavailability and spatial distribution of fatty acids in the rat retina after dietary omega-3 supplementation

https://doi.org/10.1194/jlr.RA120001057Get rights and content
Under a Creative Commons license
open access

Spatial changes of FAs in the retina in response to different dietary n-3 formulations have never been explored, although a diet rich in EPA and DHA is recommended to protect the retina against the effects of aging. In this study, Wistar rats were fed for 8 weeks with balanced diet including either EPA-containing phospholipids (PLs), EPA-containing TGs, DHA-containing PLs, or DHA-containing TGs. Qualitative changes in FA composition of plasma, erythrocytes, and retina were evaluated by gas chromatography-flame ionization detector. Following the different dietary intakes, changes to the quantity and spatial organization of PC and PE species in retina were determined by LC coupled to MS/MS and MALDI coupled to MS imaging. The omega-3 content in the lipids of plasma and erythrocytes suggests that PLs as well as TGs are good omega-3 carriers for retina. However, a significant increase in DHA content in retina was observed, especially molecular species as di-DHA-containing PC and PE, as well as an increase in very long chain PUFAs (more than 28 carbons) following PL-EPA and TG-DHA diets only. All supplemented diets triggered spatial organization changes of DHA in the photoreceptor layer around the optic nerve. Taken together, these findings suggest that dietary omega-3 supplementation can modify the content of FAs in the rat retina.

diet and dietary lipids
docosahexaenoic acid
eicosapentaenoic acid
lipid biochemistry
lipid spatial organization
omega-3 fatty acids
phosphatidylcholine
phospholipids
triglycerides
very long chain polyunsaturated fatty acids

Cited by (0)

Author contributions—E.V., B.J., W.C.G., S.K., O.B., N.A., L.B., and N.G.B. conceptualization; E.V., B.J., W.C.G., S.K., O.B., N.A., L.B., and N.G.B. design; E.V., B.J., W.C.G., M-A.M., L.M., S.G., S.K., and S.C. data acquisition and/or analyses; E.V., B.J., W.C.G., S.K., S.C., O.B., N.A., L.B., and N.G.B. data interpretation; E.V., B.J., W.C.G., S.K., S.C., L.B., and N.G.B. writing. All authors reviewed the final version of the manuscript.

This article contains supplemental data.

Funding and other information—This work was supported by the Regional Council of Burgundy France, FEDER (European Funding for Regional Economical Development), Association Nationale Recherche Technologie, Fondation de France/Fondation de l'Oeil. Grant ANR-11-LABEX-0021 was provided by the French National Research Agency (ANR). Additional support was provided by National Eye Institute Grant EY005121 and the Eye Ear Nose Throat (EENT) Foundation of New Orleans to N.B.Z. E.V. is a PhD fellow from Horus Pharma Laboratories. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Conflict of interest—The authors declare that they have no conflicts of interest with the contents of this article.

Abbreviations

    ACN

    acetonitrile

    ALA

    α-linolenic acid

    AMD

    age-related macular degeneration

    DHB

    2,5-dihydroxybenzoic acid

    DPA

    docosapentaenoic acid

    ELOVL

    elongation of very long chain fatty-acids

    HILIC

    hydrophilic interaction LC

    IMS

    imaging MS

    LA

    linoleic acid

    LC-PUFA

    long chain PUFA

    MAG

    monoacylglycerol

    PL

    phospholipid

    RBC

    red blood cell

    RPE

    retinal pigment epithelium

    VLC-PUFA

    very long chain PUFA

Manuscript received July 31, 2020, and in revised form October 26, 2020. Published, JLR Papers in Press, October 30, 2020, DOI 10.1194/jlr.RA120001057.